TRANG BROWNLEE: Open Payments
NPI 1235447780 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,673 in 140 payments from 14 companies in 2025. Trend: 2023 $1,819 · 2024 $2,656 · 2025 $2,673
Food & beverage: $2,574Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $588 |
| Janssen Biotech, Inc. | 16 | $491 |
| E.R. Squibb & Sons, L.L.C. | 13 | $337 |
| Novartis Pharmaceuticals Corporation | 16 | $268 |
| Lilly USA, LLC | 10 | $214 |
| GENZYME CORPORATION | 8 | $192 |
| UCB, Inc. | 13 | $180 |
| Galderma Laboratories, L.P. | 11 | $137 |
| Regeneron Healthcare Solutions, Inc. | 4 | $93 |
| LEO Pharma Inc. | 3 | $63 |
Products named: TREMFYA, Sotyktu, RINVOQ, SKYRIZI, DUPIXENT, COSENTYX, Bimzelx, NEMLUVIO.
Industry payments across KS — which companies pay providers there.
